Compare NVNO & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVNO | MEGL |
|---|---|---|
| Founded | 1987 | 2016 |
| Country | United States | Hong Kong |
| Employees | 37 | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5M | 5.1M |
| IPO Year | N/A | 2021 |
| Metric | NVNO | MEGL |
|---|---|---|
| Price | $10.61 | $1.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 14.1K | 12.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.30 | $0.87 |
| 52 Week High | $12.85 | $2.62 |
| Indicator | NVNO | MEGL |
|---|---|---|
| Relative Strength Index (RSI) | 54.71 | 55.98 |
| Support Level | $0.49 | $0.88 |
| Resistance Level | $12.69 | $1.18 |
| Average True Range (ATR) | 1.20 | 0.07 |
| MACD | -0.16 | 0.03 |
| Stochastic Oscillator | 36.45 | 67.20 |
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.